BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10360481)

  • 1. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.
    Tfayli A; Hentschel P; Madajewicz S; Manzione J; Chowhan N; Davis R; Roche P; Iliya A; Roque C; Meek A; Shady M
    J Neurooncol; 1999 Mar; 42(1):73-7. PubMed ID: 10360481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
    Madajewicz S; Chowhan N; Iliya A; Roque C; Beaton R; Davis R; Fertman S; Meek A; Alvarez O; Pampati M
    Cancer; 1991 Jun; 67(11):2844-9. PubMed ID: 1851050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.
    Madajewicz S; Chowhan N; Tfayli A; Roque C; Meek A; Davis R; Wolf W; Cabahug C; Roche P; Manzione J; Iliya A; Shady M; Hentschel P; Atkins H; Braun A
    Cancer; 2000 May; 88(10):2350-6. PubMed ID: 10820358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors.
    Feun LG; Wallace S; Stewart DJ; Chuang VP; Yung WK; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Young SE
    Cancer; 1984 Sep; 54(5):794-9. PubMed ID: 6331626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.
    Strauss LC; Killmond TM; Carson BS; Maria BL; Wharam MD; Leventhal BG
    Med Pediatr Oncol; 1991; 19(1):16-21. PubMed ID: 1990253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraarterial cis-platinum chemotherapy for patients with primary and metastatic brain tumors.
    Lehane DE; Bryan RN; Horowitz B; DeSantos L; Ehni G; Zubler MA; Moiel R; Rudolph L; Aldama-Leubbert A; Mahoney D
    Cancer Drug Deliv; 1983; 1(1):69-77. PubMed ID: 6544119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas.
    Frenay M; Lebrun C; Lonjon M; Bondiau PY; Chatel M
    Eur J Cancer; 2000 May; 36(8):1026-31. PubMed ID: 10885607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot clinical and pharmacokinetic study of intracarotid cisplatin and bleomycin.
    Feun LG; Savaraj N; Lee YY; Landy H; Martinez-Prieto J; Charnsangavej C; Post JD; Lee KF; Wallace S; Bowen B
    Sel Cancer Ther; 1991; 7(1):29-36. PubMed ID: 1718023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; DaSilva V; Richard MT; Benoit B; Belanger G; Russell N
    J Neurooncol; 1993 Jul; 17(1):71-9. PubMed ID: 8120574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
    Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
    Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
    Spiridonidis CH; Laufman LR; Jones JJ; Gray DJ; Cho CC; Young DC
    Cancer; 1996 Nov; 78(10):2070-7. PubMed ID: 8918399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumors.
    Feun LG; Lee YY; Yung WK; Charnsangavej C; Savaraj N; Tang RA; Wallace S
    Cancer Drug Deliv; 1986; 3(2):147-56. PubMed ID: 3708537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
    Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.